Pfizer Inc (PFE)
Total asset turnover
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Revenue | US$ in thousands | 63,627,000 | 58,496,000 | 100,330,000 | 81,288,000 | 41,908,000 |
| Total assets | US$ in thousands | 213,396,000 | 226,501,000 | 197,206,000 | 181,477,000 | 154,229,000 |
| Total asset turnover | 0.30 | 0.26 | 0.51 | 0.45 | 0.27 |
December 31, 2024 calculation
Total asset turnover = Revenue ÷ Total assets
= $63,627,000K ÷ $213,396,000K
= 0.30
The total asset turnover ratio for Pfizer Inc has shown fluctuations over the years, indicating varying efficiency in generating sales from its total assets. In 2020, the ratio stood at 0.27, indicating that Pfizer generated 27 cents of revenue for each dollar of total assets. This ratio increased to 0.45 in 2021, suggesting improved asset utilization. Further improvement was seen in 2022 with a total asset turnover of 0.51, signaling Pfizer's increased ability to generate sales relative to its asset base.
However, there was a notable decline in 2023, with the ratio dropping to 0.26, possibly indicating challenges in effectively utilizing assets to generate revenue. The ratio recovered slightly in 2024 to 0.30, although it remained below the 2022 level.
Overall, the trend in Pfizer's total asset turnover reflects variability in asset efficiency over the period, with notable improvements in 2021 and 2022, but some challenges in 2023. Further analysis of the company's operations and strategic decisions would be necessary to understand the factors driving these fluctuations in asset turnover.
Peer comparison
Dec 31, 2024